Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
基于rAd26和rAd5载体的异源初免-加强免疫COVID-19疫苗在健康青少年中的安全性和免疫原性:一项开放标签、非随机、多中心、1/2期剂量递增研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1228461
Tukhvatulin, Amir I; Dolzhikova, Inna V; Dzharullaeva, Alina S; Grousova, Daria M; Kovyrshina, Anna V; Zubkova, Olga V; Zorkov, Ilya D; Iliukhina, Anna A; Shelkov, Artem Y; Erokhova, Alina S; Popova, Olga; Ozharovskaia, Tatiana A; Zrelkin, Denis I; Izhaeva, Fatima M; Shcheblyakov, Dmitry V; Esmagambetov, Ilias B; Tokarskaya, Elisaveta A; Nikitenko, Natalia A; Lubenets, Nadezhda L; Khadorich, Elizaveta A; Gushchin, Vladimir A; Borzakova, Svetlana N; Vlasova, Anna V; Osmanov, Ismail M; Gorev, Valerii V; Naroditsky, Boris S; Logunov, Denis Y; Gintsburg, Alexander L